| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Net loss | -34,518,281 | -24,845,419 | -17,905,240 |
| Depreciation and amortization | 22,307 | 17,113 | 8,215 |
| Share-based compensation expense | 829,129 | 517,955 | 470,250 |
| Fair value of shares issued as non-redemption compensation | 10,835,294 | 10,835,293 | 10,724,913 |
| Gain on extinguishment of debt, net | - | - | 12,592,052 |
| Shares issued to settle debt issuance cost | 1,346,588 | - | - |
| Loss on conversion of seaport bridge, opco and po loans | - | - | 6,196,441 |
| Gain on extinguishment of debt, net | -254,530 | 4,086,709 | - |
| Amortization of debt issuance cost | 60,709 | 54,209 | 39,881 |
| Change in fair value of derivative liabilities | -827,445 | -827,445 | -827,445 |
| Change in fair value of warrant liabilities | -223,162 | -223,162 | -223,162 |
| Change in fair value of convertible notes | -51,672 | - | - |
| Change in fair value of earnout liabilities | 8,000 | 13,000 | 30,000 |
| Transaction costs expensed | 8,763,915 | 8,763,915 | 8,763,915 |
| Interest expense paid in shares | 242,748 | 155,475 | - |
| Payment of advisory and insurance expenses | 715,000 | 715,000 | 715,000 |
| Reverse recapitalization transaction | 129,676 | 129,676 | 129,676 |
| Research and development tax credit receivable | -126,286 | -65,006 | -29,324 |
| Prepaid and other current assets | 341,662 | 412,083 | 1,570,993 |
| Accounts receivable | -287,448 | -287,448 | -287,448 |
| Inventory | 115,208 | 395,623 | -112,363 |
| Accounts payable | 5,467,916 | 3,417,202 | 1,898,225 |
| Accrued liabilities | 105,198 | 108,187 | 46,150 |
| Accrued compensation | 289,882 | 388,265 | 12,228 |
| Accrued federal tax liability, including penalties and interest | -169,942 | -296,153 | -405,902 |
| Interest payable | 674,715 | 367,383 | 129,511 |
| Interest payable to related parties | 992,348 | 886,488 | 554,075 |
| Deferred revenue | -894,073 | -866,302 | -346,050 |
| Related parties payable | -33,260 | -33,260 | -83,260 |
| Net cash used in operating activities | -4,368,126 | -3,609,649 | -2,151,597 |
| Purchases of property, plant and equipment | 15,940 | 15,940 | 6,944 |
| Net cash used in investing activities | -15,940 | -15,940 | -6,944 |
| Proceeds from loans | 4,437,000 | 3,487,000 | 3,000,000 |
| Proceeds from stock options and warrants exercised | 30,010 | 30,010 | 30,010 |
| Proceeds from issuance of common stock | - | 250,000 | - |
| Payment of loans | 197,615 | 122,615 | 122,615 |
| Proceeds from issuance of common stock | 250,000 | - | - |
| Net cash provided by financing activities | 4,519,395 | 3,644,395 | 2,907,395 |
| Net increase (decrease) in cash during period | 135,329 | 18,806 | 748,854 |
| Cash and cash equivalents at beginning of period | 22,317 | 22,317 | 22,317 |
| Cash and cash equivalents at end of period | 157,646 | 41,123 | 771,171 |
ScanTech AI Systems Inc. (STAI)
ScanTech AI Systems Inc. (STAI)